Yeomans Consulting Group »

Belite Bio shares owned by Yeomans Consulting Group

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Yeomans Consulting Group from 13F filings

Historical chart of Yeomans Consulting Group investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Yeomans Consulting Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Yeomans Consulting Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $384k 2.4k 159.96

More positions owned by Yeomans Consulting Group

Vanguard Index Fds Large Cap Etf (VV)
Ishares Gold Tr Ishares New (IAU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Sei Exchange Traded Funds Enhanced Us Lrg (SEIM)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Micro-cap Etf (IWC)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Whitehall Fds Em Mk Gov Bd Etf (VWOB)
Ishares Tr Msci Eafe Min Vl (EFAV)
Dimensional Etf Trust Intl Small Cap V (DISV)

View all positions for Yeomans Consulting Group

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management
ADAR1 Capital Management

View all funds holding Belite Bio